Price (delayed)
$4.25
Market cap
$23.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.03
Enterprise value
-$5.65M
Aprea Therapeutics, Inc. is a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor
There are no recent dividends present for APRE.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.